Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 22;12(8):e0183487.
doi: 10.1371/journal.pone.0183487. eCollection 2017.

Nanofibrillar cellulose-alginate hydrogel coated surgical sutures as cell-carrier systems

Affiliations

Nanofibrillar cellulose-alginate hydrogel coated surgical sutures as cell-carrier systems

Patrick Laurén et al. PLoS One. .

Abstract

Hydrogel nanomaterials, especially those that are of non-human and non-animal origins, have great potential in biomedical and pharmaceutical sciences due to their versatility and inherent soft-tissue like properties. With the ability to simulate native tissue function, hydrogels are potentially well suited for cellular therapy applications. In this study, we have fabricated nanofibrillar cellulose-alginate (NFCA) suture coatings as biomedical devices to help overcome some of the limitations related to cellular therapy, such as low cell survivability and distribution out of target tissue. The addition of sodium alginate 8% (w/v) increased the NFCA hydrogel viscosity, storage and loss moduli by slightly under one order of magnitude, thus contributing significantly to coating strength. Confocal microscopy showed nearly 100% cell viability throughout the 2-week incubation period within and on the surface of the coating. Additionally, typical morphologies in the dual cell culture of spheroid forming HepG2 and monolayer type SK-HEP-1 were observed. Twelve out of 14 NFCA coated surgical sutures remained intact during the suturing operation with various mice and rat tissue; however, partial peeling off was observed in 2 of the coated sutures. We conclude that NFCA suture coatings could perform as cell-carrier systems for cellular based therapy and post-surgical treatment.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: All authors of this manuscript declare that no competing interests exist, and concerning affiliations (participating Universities and Made Consulting), this does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Frequency sweeps of NFCA samples.
A) Storage modulus (G’) and B) loss modulus (G”) values showed increased strength in the NFCA network with the addition of alginate. NFCA hydrogels were relatively independent of angular frequency, which indicates a more stable gel structure as opposed to native NFC, where the values shift towards higher frequencies.
Fig 2
Fig 2. Viscosity measurements of NFC and NFCA samples.
Addition of alginate increases the viscosity of the hydrogel composition. A minor increase can be observed with the incremental addition of alginate content within the mixture.
Fig 3
Fig 3. Live/Dead confocal imaging of NFCA-HepG2 threads stained with FDA (alive/green) and PI (dead/red).
A) HepG2 cells were mixed within the NFCA before crosslinking; after 1-week of incubation and C) after 2 weeks of incubation. B) HepG2 cells were seeded on top of type-I collagen treated NFCA threads; after 1-week of incubation and D) after 2 weeks of incubation. An increase in the number of cells after the 2-week incubation period was not observed when the cells were mixed within the NFCA material. However, HepG2 clusters were growing on the surface cultures. Only a few dead cells were observed during the study period.
Fig 4
Fig 4. Confocal imaging of HepG2 and SK-HEP-1 cells stained with CTred and CTgreen, both markers for live cells.
Type-I collagen treated NFCA threads with HepG2 cells mixed within the material (red staining/HepG2 cells within the thread). A-B) HepG2 cells seeded on the surface of the NFCA threads and incubated for 72h (green). C-D) SK-HEP-1 cells seeded on the surface of the NFCA threads and incubated for 48h (green). HepG2 cells within the threads grew individually or in very small clusters; however, surface growth showed typical cluster and epithelial morphology of HepG2 and SK-HEP-1 respectively.
Fig 5
Fig 5. Confocal imaging and preparation of NFCA-HepG2 coated surgical sutures.
Live staining of CTred was performed after 72 h incubation. A) Sutures coated with NFCA-HepG2 and sewn three times through a pig liver segment indicating live HepG2 cells within the coating matrix. B, D) Preparation method of NFCA coated sutures. C) NFCA-HepG2 coating could be peeled off from the surgical suture as intact segments without damaging its tube-like structure showing live HepG2 cells remaining within the coating.
Fig 6
Fig 6. NFCA coated suture performance testing on small-animal tissues.
Suturing was completed with instrument type knots. 12 out of 14 successful sutures were performed on mouse and rat skin (A and B) in addition to rat intestine (C). Some peeling off was observed in 2 sutures during the performance testing (D). Failed sutures were clearly visible and easily noticed as long tube-like segments (D).

References

    1. Binyamin G, Shafi BM, Mery CM. Biomaterials: a primer for surgeons. Semin Pediatr Surg. 2006;1: 276–283. - PubMed
    1. Lee JE, Park S, Park M, Kim MH, Park CG, Lee SH, et al. Surgical suture assembled with polymeric drug-delivery sheet for sustained, local pain relief. Acta Biomater. 2013;9: 8318–27. doi: 10.1016/j.actbio.2013.06.003 - DOI - PubMed
    1. Guyette JP, Fakharzadeh M, Burford EJ, Tao ZW, Pins GD, Rolle MW, et al. A novel suture-based method for efficient transplantation of stem cells. J Biomed Mater Res A. 2013;101: 809–18. doi: 10.1002/jbm.a.34386 - DOI - PMC - PubMed
    1. Reckhenrich AK, Kirsch BM, Wahl EA, Schenck TL, Rezaeian F, Harder Y, et al. Surgical Sutures Filled with Adipose-Derived Stem Cells Promote Wound Healing. PLoS One. 2014;9:e91169 doi: 10.1371/journal.pone.0091169 - DOI - PMC - PubMed
    1. Herberts CA, Kwa MS, Hermsen HP. Risk factors in the development of stem cell therapy. J Transl Med. 2011;9:29 doi: 10.1186/1479-5876-9-29 - DOI - PMC - PubMed

LinkOut - more resources